Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice

By Turnbull T.   Toms G.L.   Scott R.   Bright H.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 915-922

Elsevier

Access to resources Recommend Favorite

CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice

By Harcourt J.L.   Brown M.P.   Anderson L.J.   Tripp R.A.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2964-2979

Elsevier

Access to resources Recommend Favorite

Intranasal IFN- gene transfer protects BALB/c mice against respiratory syncytial virus infection

By Kumar M.   Behera A.K.   Matsuse H.   Lockey R.F.   Mohapatra S.S.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 558-567

Elsevier

Access to resources Recommend Favorite

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

By Hancock G.E.   Speelman D.J.   Frenchick P.J.   Mineo-Kuhn M.M.   Baggs R.B.   Hahn D.J.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 391-400

Elsevier

Access to resources Recommend Favorite

Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na

By Goestch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Haeuw J.F.   Nguyen T.   Bonnefoy J.Y.   Corvaa N.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2648-2655

Elsevier

Access to resources Recommend Favorite